T 0250/23 (Insulin resistance/CAELUS) of 10.02.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T025023.20250210
- Date of decision
- 10 February 2025
- Case number
- T 0250/23
- Petition for review of
- -
- Application number
- 12758652.7
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- METHOD FOR PREVENTING AND/OR TREATING INSULIN RESISTANCE
- Applicant name
- Caelus Pharmaceuticals B.V.
Stichting Amsterdam UMC - Opponent name
- Strawman Limited
- Board
- 3.3.09
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(c)European Patent Convention Art 123(3)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 84Rules of procedure of the Boards of Appeal 2020 Art 012(4)
- Keywords
- Grounds for opposition - extension of subject-matter (yes)
Auxiliary request 1 - allowable - Catchword
- -
- Cited cases
- T 1868/16
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in the following version:
Description:
- Paragraphs 1 to 31 received during oral proceedings before the board on 10 February 2025
- Paragraphs 32 to 55 of the patent specification.
Claims:
- Nos. 1 to 14 of auxiliary request 1 as filed with the statement setting out the grounds of appeal.